Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Long

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Cancer Investigation|August 7, 2001
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group StudyJ H Edmonson, V J Suman, R J Dalton, et al.
The Journal of Laboratory and Clinical Medicine|May 11, 1999
Platelets and DAMI megakaryocytes possess beta-secretase-like activityC R Abraham, D C Marshall, H E Tibbles, et al.
Neurobiology of Aging|March 1, 1997
Activated Alzheimer disease platelets retain more beta amyloid precursor proteinT A Davies, H J Long, K Sgro, et al.
Neurobiology of Aging|March 1, 1997
Moderate and advanced Alzheimer's patients exhibit platelet activation differencesT A Davies, H J Long, H E Tibbles, et al.
Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Cancer Investigation|August 7, 2001
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group StudyJ H Edmonson, V J Suman, R J Dalton, et al.
The Journal of Laboratory and Clinical Medicine|May 11, 1999
Platelets and DAMI megakaryocytes possess beta-secretase-like activityC R Abraham, D C Marshall, H E Tibbles, et al.
Neurobiology of Aging|March 1, 1997
Activated Alzheimer disease platelets retain more beta amyloid precursor proteinT A Davies, H J Long, K Sgro, et al.
Neurobiology of Aging|March 1, 1997
Moderate and advanced Alzheimer's patients exhibit platelet activation differencesT A Davies, H J Long, H E Tibbles, et al.
Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.
Pageof 8